Publications by authors named "Marah Alzubi"
In our study of 246 newly diagnosed individuals with MGUS or SMM (115 MGUS, 131 SMM), we found that 19% reported anxiety, with no significant difference between the MGUS and SMM groups (22% vs. 17%). Those with a history of psychiatric disorders or belonging to certain racial groups were more likely to experience anxiety.
View Article and Find Full Text PDFArticle Synopsis
- * Dysgeusia was experienced by 15% of patients, while the average weight loss during treatment was around 6%, with weight loss lasting for about half of the patients even after stopping the treatment.
- * To help minimize these side effects, researchers suggest that longer intervals between doses may be beneficial, indicating a need for further studies on this approach in future clinical trials.
Article Synopsis
- - Talquetamab has been approved for treating relapsed refractory multiple myeloma, but data on patient outcomes with BCMA-based therapies after progression on talquetamab is lacking.
- - A study of 10 patients showed a median follow-up of 9.5 months and a median progression-free survival of 5.5 months after switching to BCMA therapies.
- - The study indicated that while adverse effects like cytokine release syndrome and neurotoxicity were present, using talquetamab followed by BCMA therapies is a feasible treatment option.
Purpose: Myelodysplastic syndromes (MDS) include a heterogeneous group of clonal bone marrow disorders characterized by ineffective hematopoiesis. They manifest as dysplasia in bone marrow hemopoietic elements associated with peripheral cytopenias with variable risk of AML transformation.
Patients And Methods: We analyzed retrospectively registry data collected prospectively from patients with primary MDS and patients with MDS/myeloproliferative neoplasm (MPN) in the Jordan University Hospital between January 2007 and September 2021.
The aim of this study is to compare mental wellbeing and levels of post-trauma distress between Syrian refugees who live inside camps and those who live outside camps in Jordan through a survey-based cross-sectional design, where data were collected from 240 adult Syrian refugees in Jordan. The Arabic versions of the Mental Health Continuum Short Form (MHC-SF), and the Impact of Event Scale-Revised (IES-R) were used to quantitatively measure variables through descriptive statistics and multiple comparative analysis tests. Despite having no significant correlation with residence, findings of the MHC-SF showed significance for mental wellbeing with employment status and income.
View Article and Find Full Text PDFBackground: Subgroup analyses in clinical trials assess intervention effects on specific patient subgroups, ensuring generalizability. However, they are usually only able to generate hypotheses rather than definitive conclusions. This study examined the prevalence and characteristics of post hoc subgroup analysis in oncology.
View Article and Find Full Text PDFArticle Synopsis
- Reticulocyte hemoglobin (CHr) is a key marker used to assess iron deficiency anemia (IDA) and serves as an important measure of hemoglobin levels in immature red blood cells.
- In a study involving 309 patients, mainly middle-aged females, a CHr cut-off value of 30.15 pg was identified, showing high sensitivity (87.8%) and specificity (77.7%) for detecting IDA.
- The findings suggest that CHr correlates well with other standard IDA tests and should be utilized more frequently in clinical settings due to its cost-effectiveness and reliability for diagnosing IDA.
Although COVID-19 vaccines have been available in Jordan for more than a year, Jordan suffers from a low vaccination rate. The aim of this study was to explore attitudes towards recent issues in vaccination among university students in Jordan. We adopted a cross sectional study design using an online questionnaire distributed in a Jordanian university with a medical school chosen at random.
View Article and Find Full Text PDF